nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—AGTR1—asthma	0.641	1	CbGaD
Olmesartan—Tasosartan—AGTR2—asthma	0.00213	0.256	CrCbGaD
Olmesartan—Azilsartan medoxomil—AGTR1—asthma	0.00131	0.157	CrCbGaD
Olmesartan—Forasartan—AGTR1—asthma	0.00122	0.146	CrCbGaD
Olmesartan—Tasosartan—AGTR1—asthma	0.000737	0.0887	CrCbGaD
Olmesartan—Valsartan—AGTR1—asthma	0.000639	0.0769	CrCbGaD
Olmesartan—Telmisartan—AGTR1—asthma	0.000601	0.0723	CrCbGaD
Olmesartan—Irbesartan—AGTR1—asthma	0.000485	0.0583	CrCbGaD
Olmesartan—Candesartan—AGTR1—asthma	0.000485	0.0583	CrCbGaD
Olmesartan—Losartan—AGTR1—asthma	0.000312	0.0375	CrCbGaD
Olmesartan—Losartan—ACE—asthma	0.00018	0.0217	CrCbGaD
Olmesartan—Valsartan—ALB—asthma	0.000151	0.0182	CrCbGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC30A8—asthma	9.35e-05	0.00109	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—asthma	9.34e-05	0.00108	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PDE4A—asthma	9.25e-05	0.00107	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—UTS2—asthma	9.21e-05	0.00107	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—VIP—asthma	9.21e-05	0.00107	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—C5AR1—asthma	9.21e-05	0.00107	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—ADRB2—asthma	9.11e-05	0.00106	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CCR4—asthma	8.83e-05	0.00102	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CYSLTR1—asthma	8.66e-05	0.001	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CXCL8—asthma	8.61e-05	0.000999	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—LTA4H—asthma	8.6e-05	0.000998	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—IL2RB—asthma	8.5e-05	0.000986	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PDE4D—asthma	8.42e-05	0.000977	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCL11—asthma	8.36e-05	0.00097	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—VIP—asthma	8.36e-05	0.00097	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—UTS2—asthma	8.36e-05	0.00097	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—C5AR1—asthma	8.36e-05	0.00097	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FCER2—asthma	8.24e-05	0.000957	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—C3AR1—asthma	8.24e-05	0.000957	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—C5—asthma	8.21e-05	0.000952	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PDE4B—asthma	8.21e-05	0.000952	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—TACR1—asthma	8.21e-05	0.000952	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	8.15e-05	0.000946	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALOX15—asthma	8.15e-05	0.000946	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—EDN1—asthma	8.14e-05	0.000945	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CCL5—asthma	8.08e-05	0.000937	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCR4—asthma	8.02e-05	0.00093	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CYSLTR2—asthma	7.94e-05	0.000921	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CHAT—asthma	7.78e-05	0.000902	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL2RB—asthma	7.72e-05	0.000895	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL22—asthma	7.66e-05	0.000889	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PTGDR—asthma	7.66e-05	0.000889	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LTB4R—asthma	7.66e-05	0.000889	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PDE4D—asthma	7.65e-05	0.000887	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ARG1—asthma	7.52e-05	0.000873	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CCR3—asthma	7.51e-05	0.000871	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—asthma	7.47e-05	0.000867	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—C5—asthma	7.45e-05	0.000865	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PDE4B—asthma	7.45e-05	0.000865	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—TACR1—asthma	7.45e-05	0.000865	CbGpPWpGaD
Olmesartan—Losartan—ALB—asthma	7.39e-05	0.00889	CrCbGaD
Olmesartan—AGTR1—GPCR downstream signaling—NPY—asthma	7.31e-05	0.000849	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—asthma	7.31e-05	0.000848	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CCR5—asthma	7.28e-05	0.000844	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—C3—asthma	7.11e-05	0.000825	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AGTR2—asthma	7.06e-05	0.000819	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ADCY2—asthma	6.94e-05	0.000805	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALOX5—asthma	6.93e-05	0.000804	CbGpPWpGaD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—ALB—asthma	6.89e-05	0.0008	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCR3—asthma	6.82e-05	0.000791	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALDH7A1—asthma	6.8e-05	0.000789	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—EDNRB—asthma	6.76e-05	0.000784	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—CARM1—asthma	6.69e-05	0.000777	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—NPS—asthma	6.69e-05	0.000776	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—TAC1—asthma	6.69e-05	0.000776	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LTC4S—asthma	6.67e-05	0.000774	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—NPY—asthma	6.64e-05	0.000771	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CARM1—asthma	6.61e-05	0.000767	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCR3—asthma	6.56e-05	0.000761	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ARG2—asthma	6.52e-05	0.000757	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PTGDR2—asthma	6.52e-05	0.000756	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PMCH—asthma	6.52e-05	0.000756	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NPSR1—asthma	6.52e-05	0.000756	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HRH4—asthma	6.52e-05	0.000756	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AGTR2—asthma	6.41e-05	0.000744	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CSF2RB—asthma	6.38e-05	0.00074	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—CARM1—asthma	6.29e-05	0.000729	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TACR2—asthma	6.25e-05	0.000725	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCR8—asthma	6.25e-05	0.000725	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—IL5—asthma	6.22e-05	0.000722	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—EDNRB—asthma	6.14e-05	0.000712	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL17—asthma	6.13e-05	0.000711	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—TAC1—asthma	6.08e-05	0.000705	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—NPS—asthma	6.08e-05	0.000705	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—BDKRB2—asthma	6e-05	0.000696	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCR3—asthma	5.96e-05	0.000691	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—HMOX1—asthma	5.83e-05	0.000677	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—ADCY2—asthma	5.81e-05	0.000674	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—IL3—asthma	5.79e-05	0.000671	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LTA4H—asthma	5.78e-05	0.000671	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	5.78e-05	0.00067	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	5.72e-05	0.000663	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—asthma	5.7e-05	0.000662	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—POMC—asthma	5.69e-05	0.00066	CbGpPWpGaD
Olmesartan—Ill-defined disorder—Triamcinolone—asthma	5.66e-05	0.000214	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—IL5—asthma	5.65e-05	0.000655	CbGpPWpGaD
Olmesartan—Ill-defined disorder—Methylprednisolone—asthma	5.64e-05	0.000213	CcSEcCtD
Olmesartan—Alopecia—Dexamethasone—asthma	5.61e-05	0.000212	CcSEcCtD
Olmesartan—Alopecia—Betamethasone—asthma	5.61e-05	0.000212	CcSEcCtD
Olmesartan—Nausea—Salbutamol—asthma	5.6e-05	0.000212	CcSEcCtD
Olmesartan—Discomfort—Prednisolone—asthma	5.58e-05	0.000211	CcSEcCtD
Olmesartan—Angioedema—Triamcinolone—asthma	5.57e-05	0.000211	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—CCL2—asthma	5.56e-05	0.000646	CbGpPWpGaD
Olmesartan—Angioedema—Methylprednisolone—asthma	5.56e-05	0.00021	CcSEcCtD
Olmesartan—Myalgia—Hydrocortisone—asthma	5.51e-05	0.000208	CcSEcCtD
Olmesartan—Malaise—Triamcinolone—asthma	5.5e-05	0.000208	CcSEcCtD
Olmesartan—Anxiety—Hydrocortisone—asthma	5.49e-05	0.000208	CcSEcCtD
Olmesartan—Malaise—Methylprednisolone—asthma	5.48e-05	0.000207	CcSEcCtD
Olmesartan—Vertigo—Triamcinolone—asthma	5.48e-05	0.000207	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	5.47e-05	0.000207	CcSEcCtD
Olmesartan—Syncope—Triamcinolone—asthma	5.47e-05	0.000207	CcSEcCtD
Olmesartan—Vertigo—Methylprednisolone—asthma	5.46e-05	0.000207	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—PDE4A—asthma	5.46e-05	0.000634	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KIF3A—asthma	5.46e-05	0.000634	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—KNG1—asthma	5.46e-05	0.000633	CbGpPWpGaD
Olmesartan—Syncope—Methylprednisolone—asthma	5.45e-05	0.000206	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—BDKRB2—asthma	5.45e-05	0.000632	CbGpPWpGaD
Olmesartan—Discomfort—Hydrocortisone—asthma	5.44e-05	0.000206	CcSEcCtD
Olmesartan—Connective tissue disorder—Prednisone—asthma	5.44e-05	0.000206	CcSEcCtD
Olmesartan—Nausea—Budesonide—asthma	5.43e-05	0.000205	CcSEcCtD
Olmesartan—Anaphylactic shock—Prednisolone—asthma	5.41e-05	0.000205	CcSEcCtD
Olmesartan—Oedema—Prednisolone—asthma	5.41e-05	0.000205	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—ALOX5AP—asthma	5.4e-05	0.000627	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALOX15—asthma	5.4e-05	0.000627	CbGpPWpGaD
Olmesartan—Loss of consciousness—Triamcinolone—asthma	5.36e-05	0.000203	CcSEcCtD
Olmesartan—Loss of consciousness—Methylprednisolone—asthma	5.35e-05	0.000202	CcSEcCtD
Olmesartan—Shock—Prednisolone—asthma	5.32e-05	0.000201	CcSEcCtD
Olmesartan—Cough—Triamcinolone—asthma	5.32e-05	0.000201	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—CXCL10—asthma	5.3e-05	0.000615	CbGpPWpGaD
Olmesartan—Anaphylactic shock—Hydrocortisone—asthma	5.28e-05	0.0002	CcSEcCtD
Olmesartan—Oedema—Hydrocortisone—asthma	5.28e-05	0.0002	CcSEcCtD
Olmesartan—Tachycardia—Prednisolone—asthma	5.28e-05	0.0002	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—ADCY2—asthma	5.27e-05	0.000612	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL3—asthma	5.25e-05	0.00061	CbGpPWpGaD
Olmesartan—Infection—Hydrocortisone—asthma	5.25e-05	0.000198	CcSEcCtD
Olmesartan—Hyperhidrosis—Prednisolone—asthma	5.23e-05	0.000198	CcSEcCtD
Olmesartan—Shock—Hydrocortisone—asthma	5.2e-05	0.000197	CcSEcCtD
Olmesartan—Myalgia—Triamcinolone—asthma	5.19e-05	0.000196	CcSEcCtD
Olmesartan—Nervous system disorder—Hydrocortisone—asthma	5.18e-05	0.000196	CcSEcCtD
Olmesartan—Myalgia—Methylprednisolone—asthma	5.18e-05	0.000196	CcSEcCtD
Olmesartan—Arthralgia—Methylprednisolone—asthma	5.18e-05	0.000196	CcSEcCtD
Olmesartan—Anxiety—Methylprednisolone—asthma	5.16e-05	0.000195	CcSEcCtD
Olmesartan—Tachycardia—Hydrocortisone—asthma	5.16e-05	0.000195	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—CHAT—asthma	5.15e-05	0.000598	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—ADRB2—asthma	5.15e-05	0.000597	CbGpPWpGaD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	5.14e-05	0.000194	CcSEcCtD
Olmesartan—Skin disorder—Hydrocortisone—asthma	5.13e-05	0.000194	CcSEcCtD
Olmesartan—Ill-defined disorder—Betamethasone—asthma	5.13e-05	0.000194	CcSEcCtD
Olmesartan—Ill-defined disorder—Dexamethasone—asthma	5.13e-05	0.000194	CcSEcCtD
Olmesartan—Discomfort—Triamcinolone—asthma	5.13e-05	0.000194	CcSEcCtD
Olmesartan—Discomfort—Methylprednisolone—asthma	5.12e-05	0.000193	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—CYSLTR1—asthma	5.11e-05	0.000593	CbGpPWpGaD
Olmesartan—Hyperhidrosis—Hydrocortisone—asthma	5.11e-05	0.000193	CcSEcCtD
Olmesartan—Angioedema—Betamethasone—asthma	5.05e-05	0.000191	CcSEcCtD
Olmesartan—Angioedema—Dexamethasone—asthma	5.05e-05	0.000191	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism—ARG1—asthma	5.05e-05	0.000586	CbGpPWpGaD
Olmesartan—Anorexia—Hydrocortisone—asthma	5.04e-05	0.00019	CcSEcCtD
Olmesartan—Angiopathy—Prednisone—asthma	5.02e-05	0.00019	CcSEcCtD
Olmesartan—Malaise—Dexamethasone—asthma	4.99e-05	0.000189	CcSEcCtD
Olmesartan—Malaise—Betamethasone—asthma	4.99e-05	0.000189	CcSEcCtD
Olmesartan—Oedema—Triamcinolone—asthma	4.97e-05	0.000188	CcSEcCtD
Olmesartan—Anaphylactic shock—Triamcinolone—asthma	4.97e-05	0.000188	CcSEcCtD
Olmesartan—Vertigo—Betamethasone—asthma	4.97e-05	0.000188	CcSEcCtD
Olmesartan—Vertigo—Dexamethasone—asthma	4.97e-05	0.000188	CcSEcCtD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ADCY2—asthma	4.96e-05	0.000576	CbGpPWpGaD
Olmesartan—Anaphylactic shock—Methylprednisolone—asthma	4.96e-05	0.000188	CcSEcCtD
Olmesartan—Syncope—Dexamethasone—asthma	4.96e-05	0.000188	CcSEcCtD
Olmesartan—Syncope—Betamethasone—asthma	4.96e-05	0.000188	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—KNG1—asthma	4.96e-05	0.000575	CbGpPWpGaD
Olmesartan—ABCC2—NRF2 pathway—TGFB1—asthma	4.95e-05	0.000574	CbGpPWpGaD
Olmesartan—Arrhythmia—Prednisone—asthma	4.94e-05	0.000187	CcSEcCtD
Olmesartan—Infection—Triamcinolone—asthma	4.94e-05	0.000187	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—CCL11—asthma	4.94e-05	0.000573	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VIP—asthma	4.94e-05	0.000573	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—UTS2—asthma	4.94e-05	0.000573	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—C5AR1—asthma	4.94e-05	0.000573	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CMA1—asthma	4.94e-05	0.000573	CbGpPWpGaD
Olmesartan—Hypotension—Hydrocortisone—asthma	4.94e-05	0.000187	CcSEcCtD
Olmesartan—Infection—Methylprednisolone—asthma	4.93e-05	0.000186	CcSEcCtD
Olmesartan—Shock—Triamcinolone—asthma	4.89e-05	0.000185	CcSEcCtD
Olmesartan—Insomnia—Prednisolone—asthma	4.89e-05	0.000185	CcSEcCtD
Olmesartan—Alopecia—Prednisone—asthma	4.89e-05	0.000185	CcSEcCtD
Olmesartan—Shock—Methylprednisolone—asthma	4.88e-05	0.000185	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—ITPR1—asthma	4.87e-05	0.000565	CbGpPWpGaD
Olmesartan—Nervous system disorder—Methylprednisolone—asthma	4.87e-05	0.000184	CcSEcCtD
Olmesartan—Loss of consciousness—Betamethasone—asthma	4.86e-05	0.000184	CcSEcCtD
Olmesartan—Loss of consciousness—Dexamethasone—asthma	4.86e-05	0.000184	CcSEcCtD
Olmesartan—Tachycardia—Triamcinolone—asthma	4.86e-05	0.000184	CcSEcCtD
Olmesartan—Mental disorder—Prednisone—asthma	4.85e-05	0.000183	CcSEcCtD
Olmesartan—Tachycardia—Methylprednisolone—asthma	4.84e-05	0.000183	CcSEcCtD
Olmesartan—Skin disorder—Methylprednisolone—asthma	4.82e-05	0.000182	CcSEcCtD
Olmesartan—Malnutrition—Prednisone—asthma	4.82e-05	0.000182	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—CXCL10—asthma	4.82e-05	0.000559	CbGpPWpGaD
Olmesartan—Musculoskeletal discomfort—Hydrocortisone—asthma	4.81e-05	0.000182	CcSEcCtD
Olmesartan—Hyperhidrosis—Triamcinolone—asthma	4.81e-05	0.000182	CcSEcCtD
Olmesartan—Hyperhidrosis—Methylprednisolone—asthma	4.8e-05	0.000181	CcSEcCtD
Olmesartan—Insomnia—Hydrocortisone—asthma	4.78e-05	0.000181	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—CCR4—asthma	4.74e-05	0.000549	CbGpPWpGaD
Olmesartan—Myalgia—Betamethasone—asthma	4.71e-05	0.000178	CcSEcCtD
Olmesartan—Myalgia—Dexamethasone—asthma	4.71e-05	0.000178	CcSEcCtD
Olmesartan—Anxiety—Betamethasone—asthma	4.69e-05	0.000177	CcSEcCtD
Olmesartan—Anxiety—Dexamethasone—asthma	4.69e-05	0.000177	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—ADRB2—asthma	4.67e-05	0.000542	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ADCY2—asthma	4.66e-05	0.000541	CbGpPWpGaD
Olmesartan—Discomfort—Dexamethasone—asthma	4.65e-05	0.000176	CcSEcCtD
Olmesartan—Discomfort—Betamethasone—asthma	4.65e-05	0.000176	CcSEcCtD
Olmesartan—Dyspepsia—Hydrocortisone—asthma	4.65e-05	0.000176	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—STAT6—asthma	4.64e-05	0.000539	CbGpPWpGaD
Olmesartan—Hypotension—Methylprednisolone—asthma	4.64e-05	0.000175	CcSEcCtD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—ALB—asthma	4.63e-05	0.000537	CbGpPWpGaD
Olmesartan—Pain—Prednisolone—asthma	4.63e-05	0.000175	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—EDN1—asthma	4.6e-05	0.000534	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALOX5—asthma	4.59e-05	0.000533	CbGpPWpGaD
Olmesartan—Decreased appetite—Hydrocortisone—asthma	4.59e-05	0.000174	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism—ALDH7A1—asthma	4.57e-05	0.00053	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CCL5—asthma	4.56e-05	0.00053	CbGpPWpGaD
Olmesartan—Gastrointestinal disorder—Hydrocortisone—asthma	4.56e-05	0.000172	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—IL2RB—asthma	4.56e-05	0.000529	CbGpPWpGaD
Olmesartan—Fatigue—Hydrocortisone—asthma	4.55e-05	0.000172	CcSEcCtD
Olmesartan—Vision blurred—Prednisone—asthma	4.54e-05	0.000172	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Triamcinolone—asthma	4.53e-05	0.000171	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Methylprednisolone—asthma	4.52e-05	0.000171	CcSEcCtD
Olmesartan—Pain—Hydrocortisone—asthma	4.52e-05	0.000171	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—PDE4D—asthma	4.52e-05	0.000524	CbGpPWpGaD
Olmesartan—Anaphylactic shock—Betamethasone—asthma	4.51e-05	0.000171	CcSEcCtD
Olmesartan—Anaphylactic shock—Dexamethasone—asthma	4.51e-05	0.000171	CcSEcCtD
Olmesartan—Oedema—Betamethasone—asthma	4.51e-05	0.000171	CcSEcCtD
Olmesartan—Oedema—Dexamethasone—asthma	4.51e-05	0.000171	CcSEcCtD
Olmesartan—Insomnia—Triamcinolone—asthma	4.5e-05	0.00017	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—CSF2—asthma	4.5e-05	0.000522	CbGpPWpGaD
Olmesartan—Insomnia—Methylprednisolone—asthma	4.49e-05	0.00017	CcSEcCtD
Olmesartan—Infection—Dexamethasone—asthma	4.48e-05	0.00017	CcSEcCtD
Olmesartan—Infection—Betamethasone—asthma	4.48e-05	0.00017	CcSEcCtD
Olmesartan—Ill-defined disorder—Prednisone—asthma	4.47e-05	0.000169	CcSEcCtD
Olmesartan—Feeling abnormal—Prednisolone—asthma	4.46e-05	0.000169	CcSEcCtD
Olmesartan—Anaemia—Prednisone—asthma	4.45e-05	0.000168	CcSEcCtD
Olmesartan—Shock—Betamethasone—asthma	4.44e-05	0.000168	CcSEcCtD
Olmesartan—Shock—Dexamethasone—asthma	4.44e-05	0.000168	CcSEcCtD
Olmesartan—Nervous system disorder—Dexamethasone—asthma	4.43e-05	0.000167	CcSEcCtD
Olmesartan—Nervous system disorder—Betamethasone—asthma	4.43e-05	0.000167	CcSEcCtD
Olmesartan—Agitation—Prednisone—asthma	4.43e-05	0.000167	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—ITPR1—asthma	4.42e-05	0.000513	CbGpPWpGaD
Olmesartan—Thrombocytopenia—Betamethasone—asthma	4.42e-05	0.000167	CcSEcCtD
Olmesartan—Thrombocytopenia—Dexamethasone—asthma	4.42e-05	0.000167	CcSEcCtD
Olmesartan—Tachycardia—Dexamethasone—asthma	4.41e-05	0.000167	CcSEcCtD
Olmesartan—Tachycardia—Betamethasone—asthma	4.41e-05	0.000167	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—C5—asthma	4.4e-05	0.000511	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PDE4B—asthma	4.4e-05	0.000511	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TACR1—asthma	4.4e-05	0.000511	CbGpPWpGaD
Olmesartan—Angioedema—Prednisone—asthma	4.4e-05	0.000166	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—CXCL8—asthma	4.4e-05	0.00051	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—asthma	4.38e-05	0.000509	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CARM1—asthma	4.38e-05	0.000508	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ARG2—asthma	4.38e-05	0.000508	CbGpPWpGaD
Olmesartan—Dyspepsia—Triamcinolone—asthma	4.38e-05	0.000166	CcSEcCtD
Olmesartan—Dyspepsia—Methylprednisolone—asthma	4.37e-05	0.000165	CcSEcCtD
Olmesartan—Hyperhidrosis—Dexamethasone—asthma	4.36e-05	0.000165	CcSEcCtD
Olmesartan—Hyperhidrosis—Betamethasone—asthma	4.36e-05	0.000165	CcSEcCtD
Olmesartan—Feeling abnormal—Hydrocortisone—asthma	4.35e-05	0.000165	CcSEcCtD
Olmesartan—Malaise—Prednisone—asthma	4.34e-05	0.000164	CcSEcCtD
Olmesartan—Vertigo—Prednisone—asthma	4.33e-05	0.000164	CcSEcCtD
Olmesartan—Gastrointestinal pain—Hydrocortisone—asthma	4.32e-05	0.000163	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—DCN—asthma	4.32e-05	0.000501	CbGpPWpGaD
Olmesartan—Syncope—Prednisone—asthma	4.32e-05	0.000163	CcSEcCtD
Olmesartan—Anorexia—Betamethasone—asthma	4.3e-05	0.000163	CcSEcCtD
Olmesartan—Anorexia—Dexamethasone—asthma	4.3e-05	0.000163	CcSEcCtD
Olmesartan—Urticaria—Prednisolone—asthma	4.3e-05	0.000162	CcSEcCtD
Olmesartan—Fatigue—Triamcinolone—asthma	4.29e-05	0.000162	CcSEcCtD
Olmesartan—Fatigue—Methylprednisolone—asthma	4.28e-05	0.000162	CcSEcCtD
Olmesartan—Pain—Triamcinolone—asthma	4.25e-05	0.000161	CcSEcCtD
Olmesartan—Loss of consciousness—Prednisone—asthma	4.23e-05	0.00016	CcSEcCtD
Olmesartan—Hypotension—Dexamethasone—asthma	4.22e-05	0.000159	CcSEcCtD
Olmesartan—Hypotension—Betamethasone—asthma	4.22e-05	0.000159	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—ALDH2—asthma	4.2e-05	0.000488	CbGpPWpGaD
Olmesartan—Urticaria—Hydrocortisone—asthma	4.2e-05	0.000159	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—EDN1—asthma	4.18e-05	0.000485	CbGpPWpGaD
Olmesartan—Body temperature increased—Hydrocortisone—asthma	4.18e-05	0.000158	CcSEcCtD
Olmesartan—Abdominal pain—Hydrocortisone—asthma	4.18e-05	0.000158	CcSEcCtD
Olmesartan—ABCC2—Transmembrane transport of small molecules—HMOX1—asthma	4.17e-05	0.000484	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCL5—asthma	4.15e-05	0.000481	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PLA2G4A—asthma	4.13e-05	0.000479	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CCR5—asthma	4.11e-05	0.000477	CbGpPWpGaD
Olmesartan—Musculoskeletal discomfort—Dexamethasone—asthma	4.11e-05	0.000155	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Betamethasone—asthma	4.11e-05	0.000155	CcSEcCtD
Olmesartan—Arthralgia—Prednisone—asthma	4.1e-05	0.000155	CcSEcCtD
Olmesartan—Myalgia—Prednisone—asthma	4.1e-05	0.000155	CcSEcCtD
Olmesartan—Feeling abnormal—Triamcinolone—asthma	4.1e-05	0.000155	CcSEcCtD
Olmesartan—Feeling abnormal—Methylprednisolone—asthma	4.09e-05	0.000155	CcSEcCtD
Olmesartan—Anxiety—Prednisone—asthma	4.09e-05	0.000155	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—CSF2—asthma	4.08e-05	0.000474	CbGpPWpGaD
Olmesartan—Insomnia—Betamethasone—asthma	4.08e-05	0.000154	CcSEcCtD
Olmesartan—Insomnia—Dexamethasone—asthma	4.08e-05	0.000154	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	4.07e-05	0.000154	CcSEcCtD
Olmesartan—Gastrointestinal pain—Methylprednisolone—asthma	4.06e-05	0.000153	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—IL2RA—asthma	4.05e-05	0.00047	CbGpPWpGaD
Olmesartan—Discomfort—Prednisone—asthma	4.05e-05	0.000153	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—asthma	4.04e-05	0.000469	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCR3—asthma	4.03e-05	0.000467	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—C3—asthma	4.02e-05	0.000466	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTT1—asthma	4e-05	0.000464	CbGpPWpGaD
Olmesartan—Dyspepsia—Betamethasone—asthma	3.97e-05	0.00015	CcSEcCtD
Olmesartan—Dyspepsia—Dexamethasone—asthma	3.97e-05	0.00015	CcSEcCtD
Olmesartan—Urticaria—Triamcinolone—asthma	3.95e-05	0.000149	CcSEcCtD
Olmesartan—Urticaria—Methylprednisolone—asthma	3.94e-05	0.000149	CcSEcCtD
Olmesartan—Body temperature increased—Triamcinolone—asthma	3.93e-05	0.000149	CcSEcCtD
Olmesartan—Oedema—Prednisone—asthma	3.93e-05	0.000149	CcSEcCtD
Olmesartan—Anaphylactic shock—Prednisone—asthma	3.93e-05	0.000149	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—NPY—asthma	3.92e-05	0.000455	CbGpPWpGaD
Olmesartan—Abdominal pain—Methylprednisolone—asthma	3.92e-05	0.000148	CcSEcCtD
Olmesartan—Decreased appetite—Dexamethasone—asthma	3.92e-05	0.000148	CcSEcCtD
Olmesartan—Decreased appetite—Betamethasone—asthma	3.92e-05	0.000148	CcSEcCtD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—HMOX1—asthma	3.92e-05	0.000455	CbGpPWpGaD
Olmesartan—Infection—Prednisone—asthma	3.91e-05	0.000148	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Dexamethasone—asthma	3.9e-05	0.000147	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Betamethasone—asthma	3.9e-05	0.000147	CcSEcCtD
Olmesartan—Fatigue—Betamethasone—asthma	3.89e-05	0.000147	CcSEcCtD
Olmesartan—Fatigue—Dexamethasone—asthma	3.89e-05	0.000147	CcSEcCtD
Olmesartan—Shock—Prednisone—asthma	3.87e-05	0.000146	CcSEcCtD
Olmesartan—Pain—Betamethasone—asthma	3.86e-05	0.000146	CcSEcCtD
Olmesartan—Pain—Dexamethasone—asthma	3.86e-05	0.000146	CcSEcCtD
Olmesartan—Nervous system disorder—Prednisone—asthma	3.85e-05	0.000146	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	3.84e-05	0.000446	CbGpPWpGaD
Olmesartan—Tachycardia—Prednisone—asthma	3.84e-05	0.000145	CcSEcCtD
Olmesartan—Skin disorder—Prednisone—asthma	3.82e-05	0.000144	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—PPP2CA—asthma	3.8e-05	0.000441	CbGpPWpGaD
Olmesartan—Hyperhidrosis—Prednisone—asthma	3.8e-05	0.000144	CcSEcCtD
Olmesartan—Asthenia—Hydrocortisone—asthma	3.79e-05	0.000143	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—AGTR2—asthma	3.79e-05	0.000439	CbGpPWpGaD
Olmesartan—Anorexia—Prednisone—asthma	3.75e-05	0.000142	CcSEcCtD
Olmesartan—Pruritus—Hydrocortisone—asthma	3.74e-05	0.000141	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—CCR5—asthma	3.73e-05	0.000433	CbGpPWpGaD
Olmesartan—Feeling abnormal—Betamethasone—asthma	3.72e-05	0.000141	CcSEcCtD
Olmesartan—Feeling abnormal—Dexamethasone—asthma	3.72e-05	0.000141	CcSEcCtD
Olmesartan—Gastrointestinal pain—Dexamethasone—asthma	3.69e-05	0.00014	CcSEcCtD
Olmesartan—Gastrointestinal pain—Betamethasone—asthma	3.69e-05	0.00014	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—asthma	3.68e-05	0.000427	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL2RA—asthma	3.68e-05	0.000427	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—C3—asthma	3.65e-05	0.000423	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALOX5AP—asthma	3.63e-05	0.000421	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALOX15—asthma	3.63e-05	0.000421	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EDNRB—asthma	3.63e-05	0.000421	CbGpPWpGaD
Olmesartan—Diarrhoea—Hydrocortisone—asthma	3.61e-05	0.000137	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—TAC1—asthma	3.59e-05	0.000416	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NPS—asthma	3.59e-05	0.000416	CbGpPWpGaD
Olmesartan—Urticaria—Betamethasone—asthma	3.59e-05	0.000136	CcSEcCtD
Olmesartan—Urticaria—Dexamethasone—asthma	3.59e-05	0.000136	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Prednisone—asthma	3.58e-05	0.000135	CcSEcCtD
Olmesartan—Dizziness—Prednisolone—asthma	3.58e-05	0.000135	CcSEcCtD
Olmesartan—Asthenia—Triamcinolone—asthma	3.57e-05	0.000135	CcSEcCtD
Olmesartan—Body temperature increased—Dexamethasone—asthma	3.57e-05	0.000135	CcSEcCtD
Olmesartan—Body temperature increased—Betamethasone—asthma	3.57e-05	0.000135	CcSEcCtD
Olmesartan—Abdominal pain—Dexamethasone—asthma	3.57e-05	0.000135	CcSEcCtD
Olmesartan—Abdominal pain—Betamethasone—asthma	3.57e-05	0.000135	CcSEcCtD
Olmesartan—Asthenia—Methylprednisolone—asthma	3.56e-05	0.000135	CcSEcCtD
Olmesartan—Insomnia—Prednisone—asthma	3.56e-05	0.000134	CcSEcCtD
Olmesartan—Pruritus—Triamcinolone—asthma	3.52e-05	0.000133	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—CXCR3—asthma	3.52e-05	0.000408	CbGpPWpGaD
Olmesartan—Pruritus—Methylprednisolone—asthma	3.51e-05	0.000133	CcSEcCtD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ALB—asthma	3.5e-05	0.000406	CbGpPWpGaD
Olmesartan—Dizziness—Hydrocortisone—asthma	3.49e-05	0.000132	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism—CHAT—asthma	3.46e-05	0.000402	CbGpPWpGaD
Olmesartan—Dyspepsia—Prednisone—asthma	3.46e-05	0.000131	CcSEcCtD
Olmesartan—Decreased appetite—Prednisone—asthma	3.42e-05	0.000129	CcSEcCtD
Olmesartan—Rash—Prednisolone—asthma	3.41e-05	0.000129	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—CYBA—asthma	3.41e-05	0.000395	CbGpPWpGaD
Olmesartan—Dermatitis—Prednisolone—asthma	3.41e-05	0.000129	CcSEcCtD
Olmesartan—Diarrhoea—Methylprednisolone—asthma	3.4e-05	0.000128	CcSEcCtD
Olmesartan—Fatigue—Prednisone—asthma	3.39e-05	0.000128	CcSEcCtD
Olmesartan—Headache—Prednisolone—asthma	3.39e-05	0.000128	CcSEcCtD
Olmesartan—Constipation—Prednisone—asthma	3.36e-05	0.000127	CcSEcCtD
Olmesartan—Vomiting—Hydrocortisone—asthma	3.36e-05	0.000127	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—PARP1—asthma	3.34e-05	0.000387	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL5—asthma	3.34e-05	0.000387	CbGpPWpGaD
Olmesartan—Rash—Hydrocortisone—asthma	3.33e-05	0.000126	CcSEcCtD
Olmesartan—Dermatitis—Hydrocortisone—asthma	3.33e-05	0.000126	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—NQO1—asthma	3.32e-05	0.000385	CbGpPWpGaD
Olmesartan—Headache—Hydrocortisone—asthma	3.31e-05	0.000125	CcSEcCtD
Olmesartan—Dizziness—Triamcinolone—asthma	3.29e-05	0.000124	CcSEcCtD
Olmesartan—Dizziness—Methylprednisolone—asthma	3.28e-05	0.000124	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—ADCY2—asthma	3.25e-05	0.000377	CbGpPWpGaD
Olmesartan—Feeling abnormal—Prednisone—asthma	3.24e-05	0.000122	CcSEcCtD
Olmesartan—Asthenia—Betamethasone—asthma	3.24e-05	0.000122	CcSEcCtD
Olmesartan—Asthenia—Dexamethasone—asthma	3.24e-05	0.000122	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—asthma	3.22e-05	0.000374	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—BDKRB2—asthma	3.22e-05	0.000373	CbGpPWpGaD
Olmesartan—Gastrointestinal pain—Prednisone—asthma	3.21e-05	0.000122	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—POMC—asthma	3.21e-05	0.000373	CbGpPWpGaD
Olmesartan—Nausea—Prednisolone—asthma	3.21e-05	0.000121	CcSEcCtD
Olmesartan—Pruritus—Dexamethasone—asthma	3.19e-05	0.000121	CcSEcCtD
Olmesartan—Pruritus—Betamethasone—asthma	3.19e-05	0.000121	CcSEcCtD
Olmesartan—Vomiting—Triamcinolone—asthma	3.16e-05	0.00012	CcSEcCtD
Olmesartan—Vomiting—Methylprednisolone—asthma	3.16e-05	0.000119	CcSEcCtD
Olmesartan—Nausea—Hydrocortisone—asthma	3.14e-05	0.000119	CcSEcCtD
Olmesartan—Rash—Triamcinolone—asthma	3.14e-05	0.000119	CcSEcCtD
Olmesartan—Dermatitis—Triamcinolone—asthma	3.13e-05	0.000118	CcSEcCtD
Olmesartan—Rash—Methylprednisolone—asthma	3.13e-05	0.000118	CcSEcCtD
Olmesartan—Dermatitis—Methylprednisolone—asthma	3.13e-05	0.000118	CcSEcCtD
Olmesartan—Urticaria—Prednisone—asthma	3.12e-05	0.000118	CcSEcCtD
Olmesartan—Headache—Triamcinolone—asthma	3.12e-05	0.000118	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—ADCY2—asthma	3.11e-05	0.000361	CbGpPWpGaD
Olmesartan—Headache—Methylprednisolone—asthma	3.11e-05	0.000118	CcSEcCtD
Olmesartan—Abdominal pain—Prednisone—asthma	3.11e-05	0.000117	CcSEcCtD
Olmesartan—Body temperature increased—Prednisone—asthma	3.11e-05	0.000117	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—IL3—asthma	3.1e-05	0.00036	CbGpPWpGaD
Olmesartan—Diarrhoea—Dexamethasone—asthma	3.09e-05	0.000117	CcSEcCtD
Olmesartan—Diarrhoea—Betamethasone—asthma	3.09e-05	0.000117	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism—ALOX5—asthma	3.09e-05	0.000358	CbGpPWpGaD
Olmesartan—Dizziness—Dexamethasone—asthma	2.98e-05	0.000113	CcSEcCtD
Olmesartan—Dizziness—Betamethasone—asthma	2.98e-05	0.000113	CcSEcCtD
Olmesartan—Nausea—Triamcinolone—asthma	2.95e-05	0.000112	CcSEcCtD
Olmesartan—Nausea—Methylprednisolone—asthma	2.95e-05	0.000111	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism—CARM1—asthma	2.94e-05	0.000342	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KNG1—asthma	2.93e-05	0.00034	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—POMC—asthma	2.92e-05	0.000339	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—DCN—asthma	2.9e-05	0.000337	CbGpPWpGaD
Olmesartan—Vomiting—Dexamethasone—asthma	2.87e-05	0.000109	CcSEcCtD
Olmesartan—Vomiting—Betamethasone—asthma	2.87e-05	0.000109	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—CCL2—asthma	2.86e-05	0.000331	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6R—asthma	2.85e-05	0.00033	CbGpPWpGaD
Olmesartan—Rash—Betamethasone—asthma	2.85e-05	0.000108	CcSEcCtD
Olmesartan—Rash—Dexamethasone—asthma	2.85e-05	0.000108	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—CXCL10—asthma	2.84e-05	0.00033	CbGpPWpGaD
Olmesartan—Dermatitis—Dexamethasone—asthma	2.84e-05	0.000108	CcSEcCtD
Olmesartan—Dermatitis—Betamethasone—asthma	2.84e-05	0.000108	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—RHOA—asthma	2.83e-05	0.000329	CbGpPWpGaD
Olmesartan—Headache—Dexamethasone—asthma	2.83e-05	0.000107	CcSEcCtD
Olmesartan—Headache—Betamethasone—asthma	2.83e-05	0.000107	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism—ALDH2—asthma	2.82e-05	0.000328	CbGpPWpGaD
Olmesartan—Asthenia—Prednisone—asthma	2.82e-05	0.000107	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—asthma	2.81e-05	0.000326	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NTRK1—asthma	2.79e-05	0.000324	CbGpPWpGaD
Olmesartan—Pruritus—Prednisone—asthma	2.78e-05	0.000105	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—GSTP1—asthma	2.77e-05	0.000321	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ADRB2—asthma	2.76e-05	0.00032	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—HMOX1—asthma	2.73e-05	0.000317	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ITPR1—asthma	2.73e-05	0.000316	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—asthma	2.71e-05	0.000315	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CAT—asthma	2.7e-05	0.000313	CbGpPWpGaD
Olmesartan—Diarrhoea—Prednisone—asthma	2.69e-05	0.000102	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism—GSTT1—asthma	2.69e-05	0.000312	CbGpPWpGaD
Olmesartan—Nausea—Dexamethasone—asthma	2.68e-05	0.000101	CcSEcCtD
Olmesartan—Nausea—Betamethasone—asthma	2.68e-05	0.000101	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—ITPR1—asthma	2.61e-05	0.000303	CbGpPWpGaD
Olmesartan—Dizziness—Prednisone—asthma	2.6e-05	9.83e-05	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—RHOA—asthma	2.57e-05	0.000298	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PLA2G4A—asthma	2.55e-05	0.000295	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTM1—asthma	2.55e-05	0.000295	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ALB—asthma	2.51e-05	0.000291	CbGpPWpGaD
Olmesartan—Vomiting—Prednisone—asthma	2.5e-05	9.45e-05	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—CD86—asthma	2.49e-05	0.000289	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCL8—asthma	2.49e-05	0.000288	CbGpPWpGaD
Olmesartan—Rash—Prednisone—asthma	2.48e-05	9.37e-05	CcSEcCtD
Olmesartan—Dermatitis—Prednisone—asthma	2.48e-05	9.36e-05	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—asthma	2.47e-05	0.000287	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EDN1—asthma	2.47e-05	0.000286	CbGpPWpGaD
Olmesartan—Headache—Prednisone—asthma	2.46e-05	9.31e-05	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—CCL5—asthma	2.45e-05	0.000284	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PLA2G4A—asthma	2.44e-05	0.000283	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CSF2—asthma	2.41e-05	0.00028	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—IL2—asthma	2.38e-05	0.000276	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ALB—asthma	2.35e-05	0.000273	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SMAD3—asthma	2.35e-05	0.000272	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPP2CA—asthma	2.34e-05	0.000272	CbGpPWpGaD
Olmesartan—Nausea—Prednisone—asthma	2.33e-05	8.83e-05	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—CXCL8—asthma	2.26e-05	0.000262	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PPP2CA—asthma	2.25e-05	0.000261	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NQO1—asthma	2.23e-05	0.000259	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCR5—asthma	2.21e-05	0.000256	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ADCY2—asthma	2.18e-05	0.000253	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL2RA—asthma	2.17e-05	0.000252	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—asthma	2.17e-05	0.000251	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL2—asthma	2.16e-05	0.00025	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—C3—asthma	2.16e-05	0.00025	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PDGFB—asthma	2.1e-05	0.000243	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LEP—asthma	2.01e-05	0.000233	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FN1—asthma	1.89e-05	0.00022	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—asthma	1.89e-05	0.000219	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTP1—asthma	1.86e-05	0.000216	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HMOX1—asthma	1.84e-05	0.000213	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ITPR1—asthma	1.83e-05	0.000212	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CAT—asthma	1.81e-05	0.00021	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—POMC—asthma	1.8e-05	0.000209	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—POMC—asthma	1.72e-05	0.0002	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTM1—asthma	1.71e-05	0.000198	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PLA2G4A—asthma	1.71e-05	0.000198	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL2—asthma	1.69e-05	0.000196	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6R—asthma	1.68e-05	0.000195	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—EGFR—asthma	1.65e-05	0.000191	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALB—asthma	1.64e-05	0.00019	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPP2CA—asthma	1.58e-05	0.000183	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SERPINE1—asthma	1.57e-05	0.000183	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NOS3—asthma	1.57e-05	0.000182	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RHOA—asthma	1.52e-05	0.000176	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOS3—asthma	1.5e-05	0.000174	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTGS2—asthma	1.44e-05	0.000167	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL8—asthma	1.33e-05	0.000155	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL2—asthma	1.27e-05	0.000148	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6—asthma	1.27e-05	0.000147	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTEN—asthma	1.25e-05	0.000145	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—POMC—asthma	1.21e-05	0.00014	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MMP9—asthma	1.21e-05	0.00014	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PTEN—asthma	1.2e-05	0.000139	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALB—asthma	1.1e-05	0.000128	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VEGFA—asthma	1.08e-05	0.000126	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—STAT3—asthma	1.07e-05	0.000124	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NOS3—asthma	1.05e-05	0.000122	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TGFB1—asthma	9.94e-06	0.000115	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EGFR—asthma	9.75e-06	0.000113	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTGS2—asthma	9.64e-06	0.000112	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTEN—asthma	8.41e-06	9.76e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6—asthma	7.49e-06	8.69e-05	CbGpPWpGaD
